| Literature DB >> 24498419 |
Chang-Ming Guo1, Rong-Rong Chen1, Dildar Hussain Kalhoro1, Zhao-Fei Wang1, Guang-Jin Liu1, Cheng-Ping Lu1, Yong-Jie Liu1.
Abstract
Streptococcus agalactiae, long recognized as a mammalian pathogen, is an emerging concern with regard to fish. In this study, we used a mouse model and in vitro cell infection to evaluate the pathogenetic characteristics of S. agalactiae GD201008-001, isolated from tilapia in China. This bacterium was found to be highly virulent and capable of inducing brain damage by migrating into the brain by crossing the blood-brain barrier (BBB). The phagocytosis assays indicated that this bacterium could be internalized by murine macrophages and survive intracellularly for more than 24 h, inducing injury to macrophages. Further, selective capture of transcribed sequences (SCOTS) was used to investigate microbial gene expression associated with intracellular survival. This positive cDNA selection technique identified 60 distinct genes that could be characterized into 6 functional categories. More than 50% of the differentially expressed genes were involved in metabolic adaptation. Some genes have previously been described as associated with virulence in other bacteria, and four showed no significant similarities to any other previously described genes. This study constitutes the first step in further gene expression analyses that will lead to a better understanding of the molecular mechanisms used by S. agalactiae to survive in macrophages and to cross the BBB.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24498419 PMCID: PMC3912197 DOI: 10.1371/journal.pone.0087980
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Determination of LD50 in BALB/c mice challenged with S. agalactiae GD201008-001.
| Dose of challenge CFU/(0.1 ml) | Number of death/total | ||
| 12 h.p.i. | 24 h.p.i. | 36 h.p.i. | |
| 1×104 | 0/10 | 10/10 | 10/10 |
| 1×103 | 0/10 | 8/10 | 10/10 |
| 1×102 | 0/10 | 6/10 | 10/10 |
| 1×101 | 0/10 | 5/10 | 10/10 |
| PBS | 0/10 | 0/10 | 0/10 |
| LD50 | <1×101CFU | ||
Figure 1Recovery of bacteria from liver, spleen, brain and blood of mice infected with GD201008-001.
Recovered bacteria are expressed as CFU per gram of liver, spleen or brain and CFU per milliliter of blood.
Figure 2Histopathological changes shown by H&E staining in collected brains from mice infected with GD201008-001 at 20 h.p.i.
me = meninges;mi = microglia;gn = glial nodules;hc = Hippocampus;nf = nerve fibers. (A) Prominent meningeal hemorrhage and erythrocyte aggregation in the meninges (400×). (B) Microglial cells showing an increase in the number and volume. Glial nodules were distributed (400×). (C) Lytic and necrotic hippocampus (400×). (D) Nerve fibers showing severe damage (400×). (E) and (F) No histopathological changes in sham infection control (injected with PBS) (400×). Scale bar = 20 µm.
Figure 3Immunohistochemical detection of bacterial antigen in collected brains from mice infected with GD201008-001at 20 h.p.i..
bv = blood vessel;mi = microglia;gn = glial nodules;hc = Hippocampus;nf = nerve fibers (A) Positive stain in the microglia (400×). (B) Bacterial antigens were detected in the glial nodules (400×). (C) Intense antigen staining in the hippocampus. (D) A large amount of bacterial antigens were detected in the nerve fibers (400×). (E) Negative control (injected with GBS, stained with unimmunized rabbit serum) showed clean background (400×). (F) Sham mice (injected with PBS, stained with immunized rabbit serum) showed no antigen staining (400×). Scale bar = 20 µm.
Figure 4Fluorescence microscopy-based phagocytosis of GFP- expressing S. agalactiae.
GFP expressing bacteria were internalized by RAW264.7(1000×). Scale bar = 20 µm.
Figure 5Phagocytosis of GD201008-001 by RAW264.7 macrophages.
At 1(means ± S.D. obtained from three independent experiments, n = 4). An asterisk indicates a significant difference versus the phagocytosis values from the group treated at an MOI of 1 (P<0.05).
Figure 6Intracellular survival of S. agalactiae within RAW264.7 macrophages.
RAW264.7 cells were infected with S. agalactiae (MOI = 1) and phagocytosis was left to proceed for 1 h. Antibiotics were then added for a period of 1 h. This initial antibiotic-treatment was extended for different times up to 24 h and cells were lysed to quantify the intracellular bacteria by viable plate counting. The results are expressed as the intracellular survival rates of the bacteria (means± SD obtained from three independent experiments, n = 4). An asterisk indicates a significant difference versus the intracellular bacteria survival rate of the 1 h.p.i group (P<0.05).
Figure 7Cytotoxic effect of S. agalactiae on RAW264.7 macrophages.
The percentage of macrophage cytotoxicity was determined by measuring LDH release in the presence of different concentrations (MOI of 1, 10 or 100) of S. agalactiae GD201008-001 after a 4 h incubation at 37°C. An asterisk indicates that the bacterial cytotoxicity is significantly different (p<0.05) from the cytotoxicity value at an MOI of 1. (n = 4).
Figure 8Southern dot blot analysis of selected SCOTS clones.
Southern dot blot showing (I) SCOTS clones (each dot corresponds to one clone in Table 2) and (II) 0.1 µg (top) or 1 µg (bottom) of genomic S. agalactiae DNA as positive controls, hybridized to a digoxigenin (DIG)-labeled probe generated from RAW264.7-derived (a) or culture-derived cDNA (b) after three rounds of normalization.
Genes identified by SCOTS that are differentially expressed by S. agalactiae upon interaction with RAW264.7.
| Function and clone | Gene and/or possible function | GenBank Identification | Reference(s) |
|
| |||
| Clone A1 |
| YP_330368.1 | |
| cyclopropane-fatty-acyl-phospholipid synthase ( | |||
| Clone A2 |
| ZP_08649940.1 |
|
| D-alanine-D-alanyl carrier protein ligase subunit 1 ( | |||
| Clone A3 | D-alanyl-D-alanine carboxypeptidase ( | NP_687183.1 | |
| Clone A4 | cell wall surface anchor family protein ( | YP_329518.1 | |
| Clone A5 |
| ZP_08650039.1 |
|
| preprotein translocase subunit SecA ( | |||
| Clone A6 | polysaccharide biosynthesis protein ( | YP_330055.1 | |
| Clone A7 |
| NP_735499.1 | |
| hypothetical protein gbs1050 ( | |||
| Clone A8 | hypothetical protein FSLSAGS3026_12085 ( | EGS27102.1 | |
| Clone A9 | Can B domain-containing protein ( | EGS27960.1 | |
|
| |||
| Clone A10 | hypothetical protein SAG0894 ( | NP_687908.1 | |
| Clone B1 |
| YP_329897.1 |
|
| hyaluronate lyase ( | |||
| Clone B2 |
| NP_734999.1 |
|
| hypothetical protein gbs0535 ( | |||
| Clone B3 | peptidase, M20/M25/M40 family ( | ZP_00784166.1 | |
| Clone B4 | metallopeptidase, zinc binding ( | ZP_00784711.1 | |
| Clone B5 | endopeptidase O, putative ( | ZP_00788097.1 | |
| Clone B6 | hypothetical protein SAG0872 ( | NP_687886.1 | |
| Clone B7 |
| ZP_00786133.1 |
|
| pullulanase, putative ( | |||
| Clone B8 | mannosyl-glycoprotein endo-beta-N-acetylglucosamidase family protein ( | EGS28355.1 | |
| Clone B9 |
| NP_735468.1 |
|
| sensor histidine kinase CiaH ( | |||
| Clone B10 |
| NP_687649.1 | |
| phosphoserine phosphatase SerB ( | |||
| Clone C1 | acetyltransferase ( | NP_688337.1 | |
| Clone C2 | pyridine nucleotide-disulfide oxidoreductase family protein ( | NP_688351.1 | |
| Clone C3 |
| NP_688618.1 | |
| heat shock protein HtpX ( | |||
| Clone C4 | CsbD family protein ( | YP_329332.1 | |
| Clone C5 |
| YP_329765.1 | |
| formate—tetrahydrofolate ligase ( | |||
| Clone C6 |
| YP_329821.1 | |
| dihydropteroate synthase ( | |||
| Clone C7 |
| ZP_08650982.1 | |
| 3-phosphoshikimate-1-carboxyvinyltransferase ( | |||
| Clone C8 |
| ZP_00783526.1 |
|
| NADH oxidase ( | |||
| Clone C9 | morphine 6-dehydrogenase ( | ZP_08650234.1 | |
| Clone C10 |
| ZP_08650601.1 |
|
| carbamoyl-phosphate synthase, large subunit ( | |||
| Clone D1 |
| ZP_00785672.1 |
|
| methionine sulfoxide reductases B ( | |||
| Clone D2 |
| YP_330497.1 | |
| flavoprotein NrdI ( | |||
| Clone D3 |
| NP_688507.1 | |
| uridylate kinase ( | |||
| Clone D4 |
| YP_330694.1 | |
| L-serine dehydratase, iron-sulfur-dependent subunit alpha ( | |||
| Clone D5 |
| NP_688377.1 | |
| Clone D6 | hypothetical protein SAK_0322 ( | YP_328974.1 | |
| Clone D7 |
| NP_687380.1 | |
| enoyl-ACP reductase ( | |||
| Clone D8 |
| EGS28236.1 | |
| cylI protein ( | |||
| Clone D9 |
| NP_688758.1 |
|
| glyceraldehyde-3-phosphate dehydrogenase ( | |||
| Clone D10 | glycosyl hydrolase ( | YP_329453.1 | |
| Clone E1 |
| YP_329455.1 |
|
| catabolite control protein A ( | |||
|
| |||
| Clone E2 | voltage-gated chloride channel family protein ( | NP_687570.1 | |
| Clone E3 | ABC transporter ATP-binding protein ( | NP_689021.1 | |
| Clone E4 | oligopeptide ABC transporter oligopeptide-binding protein ( | NP_687222.1 | |
| Clone E5 | thiW protein ( | ZP_08650771.1 | |
|
| |||
| Clone E6 |
| NP_687507.1 | |
| cell division protein DivIB ( | |||
| Clone E7 |
| ZP_00783998.1 | |
| excinuclease ABC, A subunit ( | |||
| Clone E8 | MutS2 family protein ( | EGS26693.1 | |
| Clone E9 | IS861, transposase OrfB ( | NP_688077.1 | |
| Clone E10 |
| EGS28475.1 | |
| DNA-directed RNA polymerase subunit beta ( | |||
|
| |||
| Clone F1 |
| ZP_00783391.1 | |
| dnaJ protein ( | |||
| Clone F2 |
| ZP_00788470.1 | |
| Signal peptidase I ( | |||
|
| |||
| Clone F3 |
| YP_328819.1 | |
| heat-inducible transcription repressor ( | |||
| Clone F4 | MerR family transcriptional regulator ( | YP_330526.1 |
|
| Clone F5 | LysR family transcriptional regulator ( | NP_735874.1 |
|
| Clone F6 |
| YP_004478477.1 |
|
| response regulator protein ( | |||
|
| |||
| Clone F7 | unknown ( | ZP_00783887.1 | |
| Clone F8 | hypothetical protein SAG1491 ( | NP_688485.1 | |
| Clone F9 |
| AAL96904.1 | |
| hypothetical protein spyM18_0084 ( | |||
| Clone F10 | hypothetical protein FSLSAGS3026_02113 ( | EGS28676.1 |
Figure 9qRT-PCR determination of the genes up-regulated during intracellular survival of S. agalactiae.
Real-time RT-PCR analysis of differentially expressed genes of S. agalactiae vis a vis survival in RAW264.7 and in THB cultures. Twelve genes, aroA, clone B3 (peptidase), clone A6 (polysaccharide biosynthesis protein), clone E4 (oligopeptide ABC transporter oligopeptide -binding protein), covR, divIB, dltA, dnaJ, hylB, pulA, secA and serB were selected and amplified using real-time RT-PCR. Real time RT-PCR data for each gene is relative to that obtained for the 16S rRNA control. Data points represent the means ± SD of three independent experiments.
Characteristics of cell lines, bacterial strains, plasmids and primers used in this study.
| Cell line, strain, plasmid or primer primer | Characteristics and/or sequences | Source/reference |
|
| ||
| RAW264.7 | murine (BALB/c) macrophage cell line | ATCC |
|
| ||
| GD20101008-001 |
| Our lab |
| DH5α |
| TaKaRa |
|
| ||
| pSL5.28 | green fluorescent protein (GFP) expression |
|
| pMD18-T | Vector for cloning Taq polymerase-amplified PCR products | TaKaRa |
| pMD18-T16S | pMD18-T containing the 16S rRNA sequence (1507bp) of | This work |
| pMD18-T23S1 | pMD18-T containing the 5′end 1500 bp fragment of 23S rRNA of | This work |
| pMD18-T23S2 | pMD18-T containing the 3′end 1403 bp fragment of 23S rRNA of | This work |
|
| ||
| SCOTS-N6-01 | 5′ GACACTCTCGAGACATCACCGGTACCNNNNNN 3′ | This work |
| SCOTS-N6-02 | 5′ TGCTCTAGACGTCCTGATGGTTCNNNNNN 3′ | This work |
| SCOTS01 | 5′ | This work |
| SCOTS02 | 5′ | This work |
| 16S01 | 5′ | |
| 16S02 | 5′ | This work |
| 23SN01 | 5′ | |
| 23SN02 | 5′ | This work |
| 23SC01 | 5′ | |
| 23SC02 | 5′ | This work |
| 16S-L | 5′CGACGATACATAGCCGACCT3′ | |
| 16S-R | 5′CCGTCACTTGGTAGATTTTCC3′; amplifies | This work |
| AroA-L | 5′GATCGGATTCAGGTCGTTGT3′ | |
| AroA-R | 5′CTTTGACCAAGAGAGCAGCA3′; amplifies the sequence of | This work |
| Clone B3-L | 5′CAATCAAGCTCTCAGCCAAA3′ | |
| Clone B3-R | 5′GTGGTATGAATGGCGTCGTA3′; amplifies the sequence of clone B3 (210 bp) | This work |
| Clone A6-L | 5′ATTGCGGGAGTGGTAGGAGTT3′ | |
| Clone A6-R | 5′TGTACGTCTTGAAGCCAGTAG3′; amplifies the sequence of clone A6 (162 bp) | This work |
| Clone E4-L | 5′CGTCAGCAGTAACAGGCTCA3′ | |
| Clone E4-R | 5′CGATCCAAAGGACCGTTATG3′; amplifies the sequence of clone E4 (194 bp) | This work |
| CvoR-L | 5′TCCAATAAATGTTCGCGTGTC3′ | |
| CvoR-R | 5′CAGCTGTAGCAGAAGAAAGTG3′; amplifies the sequence of clone | This work |
| DivIB-L | 5′GACTATTTTCCGCAACCTGAC3′ | |
| DivIB-R | 5′AGAAAGACTTCCTTTTTACAA3′; amplifies the sequence of clone | This work |
| DltA-L | 5′GTTCCTAACATTTCATCAGTA3′ | |
| DltA-R | 5′GCTACTATCTAACGATTTCAA3′; amplifies the sequence of clone | This work |
| DnaJ-L | 5′TCAATGGTGGGCTTTATGGT3′ | |
| DnaJ-R | 5′TGACGTTTCTACCGCTCCAT3′; amplifies the sequence of clone | This work |
| HylB-L | 5′CGCTACTTATCGTCGTTTGGA3′ | |
| HylB-R | 5′ATTGAGCGAGGGACACCGATT3′; amplifies the sequence of clone | This work |
| PulA-L | 5′CGAGAAGCAACATATTTACCG3′ | |
| PulA-R | 5′TAACTTGGTCTGGGGCATTGT3′; amplifies the sequence of clone | This work |
| SecA-L | 5′AGATAACTCCCAGTGCTAAAC3′ | |
| SecA-R | 5′AACTGAAGATACTTATCGCCC3′; amplifies the sequence of clone | This work |
| SerB-L | 5′TCCTACCCCAGCGGATTTGAT3′ | |
| SerB-R | 5′AAAGCGAATCGTCCTGGTGTC3′; amplifies the sequence of clone | This work |